USE-DEPENDENT LOSS OF ACETYLCHOLINE-MEDIATED AND BRADYKININ-MEDIATED VASODILATION AFTER NITRIC-OXIDE SYNTHASE INHIBITION - EVIDENCE FOR PREFORMED STORES OF NITRIC OXIDE-CONTAINING FACTORS IN VASCULAR ENDOTHELIAL-CELLS
Rl. Davisson et al., USE-DEPENDENT LOSS OF ACETYLCHOLINE-MEDIATED AND BRADYKININ-MEDIATED VASODILATION AFTER NITRIC-OXIDE SYNTHASE INHIBITION - EVIDENCE FOR PREFORMED STORES OF NITRIC OXIDE-CONTAINING FACTORS IN VASCULAR ENDOTHELIAL-CELLS, Hypertension, 28(3), 1996, pp. 354-360
In the present study, we examined the possibility that the endothelium
-dependent vasodilators acetylcholine and bradykinin release preformed
poets of nitric oxide-containing factors, Successive injections of se
lected doses of acetylcholine (1.18+/-0.3 mu g/kg IV) or bradykinin (5
mu g/kg IV) caused reproducible hypotensive and vasodilator responses
within sympathetically intact and sympathetically denervated hindlimb
s of conscious rats. After administration of the nitric oxide synthesi
s inhibitor N-omega-nitro-L-arginine methyl ester (L-NAME, 25 mu mol/k
g IV), time first injection of acetylcholine or bradykinin produced pr
onounced depressor and vasodilator responses that, in the case of brad
ykinin, were greater than those observed before L-NAME administration.
However, each successive injection of acetylcholine and bradykinin pr
oduced progressively smaller responses, such that the later injections
elicited a markedly diminished hypotension and vasodilation. This ''u
se-dependent'' loss of endothelium-dependent vasodilation was not due
to the diminished vasorelaxant potency of nitric oxide-containing fact
ors because the vasodilator effects of the nitric oxide donor sodium n
itroprusside (32 mu g/kg IV) and the S-nitrosothiol compound 5-nitroso
cysteine (200 nmol/kg IV) were augmented in the presence of L-NAME. Th
ese results suggest that the use-dependent loss of the hemodynamic eff
ects of acetylcholine and bradykinin in L-NAME-treated rats may be due
to the release and subsequent depletion of a factor whose synthesis d
epends on the bioavailability of nitric oxide. Taken together, these r
esults suggest that preformed pools of nitric oxide-containing factors
exist within the endothelium of resistance vessels and that endotheli
um-dependent agonists exert their vasorelaxant effects at least in par
t by the mobilization of these preformed pools.